The Sympatics team will be at the World Evidence, Pricing and Access (EPA) Congress in Amsterdam on 3–4 March 2026, Europe’s largest congress for market access, pricing and evidence professionals.
With MFN policy rapidly reshaping the global pricing landscape, the stakes for pharmaceutical pricing and market access teams have never been higher. The introduction of mandatory IRP-based models in the US is creating ripple effects across international reference pricing systems worldwide, and companies need robust tools and strategies to navigate this evolving environment.
If you’re attending the World EPA Congress, we’d welcome the opportunity to connect. Whether you want to discuss how MFN impacts your portfolio or see a live demonstration of SyMAP — our AI-powered platform for IRP simulation, MFN modelling and global pricing strategy — we’d love to hear from you.
Get in touch to book a meeting with Chris McDonald, or come and say hello at the event.